RESUMO
AIMS: The aim of this study was to evaluate health-related quality of life (HRQoL) and joint function in tenosynovial giant cell tumour (TGCT) patients before and after surgical treatment. PATIENTS AND METHODS: This prospective cohort study run in two Dutch referral centres assessed patient-reported outcome measures (PROMs; 36-Item Short-Form Health Survey (SF-36), visual analogue scale (VAS) for pain, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)) in 359 consecutive patients with localized- and diffuse-type TGCT of large joints. Patients with recurrent disease (n = 121) and a wait-and-see policy (n = 32) were excluded. Collected data were analyzed at specified time intervals preoperatively (baseline) and/or postoperatively up to five years. RESULTS: A total of 206 TGCT patients, 108 localized- and 98 diffuse-type, were analyzed. Median age at diagnosis of localized- and diffuse-type was 41 years (interquartile range (IQR) 29 to 49) and 37 years (IQR 27 to 47), respectively. SF-36 analyses showed statistically significant and clinically relevant deteriorated preoperative and immediate postoperative scores compared with general Dutch population means, depending on subscale and TGCT subtype. After three to six months of follow-up, these scores improved to general population means and continued to be fairly stable over the following years. VAS scores, for both subtypes, showed no statistically significant or clinically relevant differences pre- or postoperatively. In diffuse-type patients, the improvement in median WOMAC score was statistically significant and clinically relevant preoperatively versus six to 24 months postoperatively, and remained up to five years' follow-up. CONCLUSION: Patients with TGCT report a better HRQoL and joint function after surgery. Pain scores, which vary hugely between patients and in patients over time, did not improve. A disease-specific PROM would help to decipher the impact of TGCT on patients' daily life and functioning in more detail. Cite this article: Bone Joint J 2019;101-B:272-280.
Assuntos
Tumor de Células Gigantes de Bainha Tendinosa/cirurgia , Recidiva Local de Neoplasia/cirurgia , Medidas de Resultados Relatados pelo Paciente , Qualidade de Vida , Atividades Cotidianas , Adulto , Feminino , Tumor de Células Gigantes de Bainha Tendinosa/reabilitação , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/reabilitação , Estudos Prospectivos , Amplitude de Movimento Articular , Recuperação de Função FisiológicaRESUMO
BACKGROUND: Musculoskeletal sarcomas comprise 1% of all malignancies in adults. Unfortunately, sometimes they are addressed in non-appropriate way requiring a more invasive procedure to achieve radical surgery at a later date. Due to incomplete predictability of their extension, scheduled reconstruction cannot be performed at times, forcing plans to change or clogging up immediate reconstruction. In this paper, the authors provide an insight in the treatment of musculoskeletal sarcomas, particularly focusing on the preoperative planning of reconstructive strategies, which is crucial in order to prevent unpleasant surprises during reconstruction. METHODS: Fifty-six consecutive patients requiring reconstructive procedures following the extirpation of tumors were recruited. All data collected during the diagnostic phase were analyzed collectively during a multi-disciplinary meeting where the surgical procedure was planned. A score system was created and results were then classified into "excellent", "good", "sufficient" and "poor". RESULTS: After a minimum follow up of 12 months, we recorded the following results: excellent in 10 patients (17.9%), good in 28 patients (50%), sufficient in 12 cases (21.4%) and poor in 6 cases (10.7%). CONCLUSIONS: The improvement of treatment and the long-lasting survival in musculoskeletal sarcoma have shifted the goal of therapeutic protocol to obtaining radical tumor removal and maximum functional restoration. When facing unpredictable extension of the resections, reconstruction may be a challenging or even impossible task to fulfil. Only meticulous preoperative planning can prevent surgeons from falling into all sorts of surgical traps following wide resections.
Assuntos
Neoplasias Ósseas/cirurgia , Extremidades/cirurgia , Salvamento de Membro/métodos , Neoplasias Musculares/cirurgia , Procedimentos de Cirurgia Plástica/métodos , Sarcoma/cirurgia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Ansiedade/etiologia , Ansiedade/terapia , Neoplasias Ósseas/reabilitação , Feminino , Seguimentos , Histiocitoma Fibroso Maligno/reabilitação , Histiocitoma Fibroso Maligno/cirurgia , Humanos , Salvamento de Membro/efeitos adversos , Masculino , Pessoa de Meia-Idade , Neoplasias Musculares/reabilitação , Mioepitelioma/reabilitação , Mioepitelioma/cirurgia , Recidiva Local de Neoplasia/prevenção & controle , Recidiva Local de Neoplasia/reabilitação , Recidiva Local de Neoplasia/cirurgia , Procedimentos de Cirurgia Plástica/psicologia , Recuperação de Função Fisiológica , Reoperação , Estudos Retrospectivos , Sarcoma/reabilitação , Retalhos Cirúrgicos , Resultado do Tratamento , Adulto JovemAssuntos
Neoplasias Encefálicas/reabilitação , Glioblastoma/reabilitação , Hospitalização , Recidiva Local de Neoplasia/reabilitação , Seleção de Pacientes , Centros de Reabilitação , Neoplasias Encefálicas/complicações , Neoplasias Encefálicas/fisiopatologia , Glioblastoma/complicações , Glioblastoma/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/complicações , Recidiva Local de Neoplasia/fisiopatologiaRESUMO
Optimum functional and aesthetic facial reconstruction is still a challenge in patients who suffer from inborn or acquired facial deformity. It is known that functional and aesthetic impairment can result in significant psychosocial strain, leading to the social isolation of patients who are affected by major facial deformities. Microvascular techniques and increasing experience in facial transplantation certainly contribute to better restorative outcomes. However, these technologies also have some drawbacks, limitations and unsolved problems. Extensive facial defects which include several aesthetic units and dentition can be restored by combining dental prostheses and anaplastology, thus providing an adequate functional and aesthetic outcome in selected patients without the drawbacks of major surgical procedures. Referring to some representative patient cases, it is shown how extreme facial disfigurement after oncological surgery can be palliated by combining intraoral dentures with extraoral facial prostheses using individualized treatment and without the need for major reconstructive surgery.
Assuntos
Face , Próteses e Implantes , Idoso , Idoso de 80 Anos ou mais , Carcinoma/reabilitação , Carcinoma/cirurgia , Carcinoma de Células Escamosas/reabilitação , Carcinoma de Células Escamosas/cirurgia , Bochecha/cirurgia , Contraindicações , Prótese Total Superior , Revestimento de Dentadura , Estética , Neoplasias Faciais/reabilitação , Neoplasias Faciais/cirurgia , Transplante de Face , Feminino , Seguimentos , Humanos , Lábio/cirurgia , Imãs , Maxila/cirurgia , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/reabilitação , Recidiva Local de Neoplasia/cirurgia , Neoplasias Nasais/reabilitação , Neoplasias Nasais/cirurgia , Órbita/cirurgia , Obturadores Palatinos , Planejamento de Assistência ao Paciente , Retenção da Prótese/instrumentaçãoRESUMO
OBJECTIVE: The aim of this study was to determine the feasibility of a combined supervised and home-based exercise intervention during chemotherapy for women with recurrent ovarian cancer. Secondary aims were to determine the impact of physical activity on physical and psychological outcomes and on chemotherapy completion rates. METHODS: Women with recurrent ovarian cancer were recruited from 3 oncology outpatient clinics in Sydney and Canberra, Australia. All participants received an individualized exercise program that consisted of 90 minutes or more of low to moderate aerobic, resistance, core stability, and balance exercise per week, for 12 weeks. Feasibility was determined by recruitment rate, retention rate, intervention adherence, and adverse events. Aerobic capacity, muscular strength, fatigue, sleep quality, quality of life, depression, and chemotherapy completion rates were assessed at weeks 0, 12, and 24. RESULTS: Thirty participants were recruited (recruitment rate, 63%), with a retention rate of 70%. Participants averaged 196 ± 138 min · wk of low to moderate physical activity throughout the intervention, with adherence to the program at 81%. There were no adverse events resulting from the exercise intervention. Participants who completed the study displayed significant improvements in quality of life (P = 0.017), fatigue (P = 0.004), mental health (P = 0.007), muscular strength (P = 0.001), and balance (P = 0.003) after the intervention. Participants completing the intervention had a higher relative dose intensity than noncompleters (P = 0.03). CONCLUSIONS: A program consisting of low to moderate exercise of 90 min · wk was achieved by two-thirds of women with recurrent ovarian cancer in this study, with no adverse events reported. Randomized control studies are required to confirm the benefits of exercise reported in this study.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Terapia por Exercício , Recidiva Local de Neoplasia/reabilitação , Neoplasias Ovarianas/reabilitação , Qualidade de Vida , Adulto , Idoso , Intervenção Educacional Precoce , Estudos de Viabilidade , Feminino , Seguimentos , Humanos , Pessoa de Meia-Idade , Invasividade Neoplásica , Recidiva Local de Neoplasia/tratamento farmacológico , Recidiva Local de Neoplasia/patologia , Estadiamento de Neoplasias , Neoplasias Ovarianas/tratamento farmacológico , Neoplasias Ovarianas/patologia , PrognósticoRESUMO
OBJECTIVE: To assess the frequency and risk factors for return to the primary acute care service among patients with lymphoma undergoing inpatient rehabilitation. DESIGN: Retrospective study. SETTING: Tertiary referral-based cancer center. PATIENTS: All patients with a history of lymphoma admitted to an inpatient rehabilitation between October 1, 2003, and January 30, 2013. MAIN OUTCOME MEASURES: Items analyzed from patient records included return to the primary acute care service with demographic information, lymphoma characteristics, medications, hospital admission characteristics, and laboratory values. RESULTS: A total of 143 unique patient admissions were analyzed, and 54 of these 143 lymphoma inpatient rehabilitation admissions (38%) returned to the primary acute care service. However, 16 of 54 (30%) returned because they needed additional chemotherapy. Excluding patients who returned to the primary acute care service for chemotherapy, statistically significant or approaching statistically significant factors (P < .10) associated with return to the primary acute care service included a creatinine level ≥ 1.3 mg/dL (P = .0002), male gender (P = .001), history of hematopoietic stem cell transplantation (P = .0355), and presence of an intravenous antifungal agent (P = .0717). Of the patients transferred back to the primary acute care service, 13 of 38 (34%) were discharged directly home, 10 of 38 (26%) died in the hospital, 7 of 38 (18%) were transferred to a subacute rehabilitation facility, and 4 of 38 (11%) were transferred to inpatient rehabilitation. CONCLUSIONS: When excluding patients who returned for chemotherapy, patients with lymphoma who were male, had undergone hematopoietic stem cell transplantation, and had a creatinine level ≥ 1.3 mg/dL demonstrated increased risk for return to the primary acute care service.
Assuntos
Serviço Hospitalar de Emergência/estatística & dados numéricos , Pacientes Internados , Linfoma/reabilitação , Recidiva Local de Neoplasia/reabilitação , Readmissão do Paciente/estatística & dados numéricos , Atenção Primária à Saúde/estatística & dados numéricos , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/epidemiologia , Estudos Retrospectivos , Estados Unidos/epidemiologia , Adulto JovemRESUMO
BACKGROUND: Combining medical and psychological knowledge and accompanying patients in an individualised path, the Oncological Rehabilitation Centre of Florence (CeRiOn) aims at offering effective integrated rehabilitation interventions and at reducing psychological distress in cancer patients. In the present observational study, we measured the psychological distress at baseline and at the end of the completed rehabilitation processes. METHODS: A total number of 627 cancer patients were treated by the psycho-oncological service at CeRiOn in 2007-2010. Among them, 99 (all women) participated in more than or equal to three sessions, were followed up for clinical and life status for at least 1 year and had a formal conclusion of their psychological rehabilitation process. For 98 cases, both a baseline and a follow-up measure of distress, by the Psychological Distress Inventory (PDI) and the Distress Thermometer (DT), were available. RESULTS: Relevant before-after amelioration in this selected group of psychologically, highly suffering cancer patients has been shown. Almost all the patients (except 20%) received both group and individual psychological support. The average rehabilitation process lasted 1.7 years. Average distress evaluation decreased from a baseline of 34.7 to 26.4 (P < 0.001) according to PDI and from 5.9 to 2.2 according to DT (P < 0.001). CONCLUSIONS: On average, quite a long psychological support time was necessary to complete the rehabilitation process. During this period, patients who had a formal conclusion of the psychological support received at CeRiOn showed a significant reduction of their distress.
Assuntos
Neoplasias da Mama/psicologia , Neoplasias da Mama/reabilitação , Procedimentos Clínicos , Centros de Reabilitação , Apoio Social , Estresse Psicológico/psicologia , Adaptação Psicológica , Adulto , Neoplasias da Mama/cirurgia , Aconselhamento , Feminino , Seguimentos , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/psicologia , Recidiva Local de Neoplasia/reabilitação , Recidiva Local de Neoplasia/cirurgia , Resultado do TratamentoRESUMO
CONTEXT: Two million people across the U.K. are living with cancer, often experienced as a long-term condition. They may have unmet needs after active treatment. Rehabilitation aims to address these needs, maximize psychological and physical function, and enable minimum dependency regardless of life expectancy. OBJECTIVES: We aimed to test, in a randomized controlled trial, the clinical and cost effectiveness of a rehabilitation intervention for patients with advanced, recurrent cancer. METHODS: We conducted a two-arm, wait-list control, randomized trial of a complex rehabilitation intervention delivered by a hospice-based multidisciplinary team vs. usual care for active, progressive, recurrent hematological and breast malignancies, with a follow-up at three months. The primary outcome was the psychological subscale of the Supportive Care Needs Survey (SCNS). Secondary outcomes were other domains of the SCNS, psychological status, continuity of care, quality of life, and resource use. RESULTS: Forty-one participants were enrolled and 36 completed the trial. The primary outcome was significantly lower in the intervention arm (adjusted difference -16.8, 95% CI -28.34 to -5.3; P = 0.006). The SCNS physical and patient care subscales (-14.2, 95% CI -26.2 to -2.2; P = 0.02 and -7.4, 95% CI -13.7 to -1.1; P = 0.02, respectively) and self-reported health state (12.8, 95% CI 3.2 to 22.4; P = 0.01) also differed significantly. The incremental cost-effectiveness ratio was £19,390 per quality-adjusted life year. CONCLUSION: This intervention significantly reduced the unmet needs of cancer survivors and it is likely that it is cost-effective. Despite small numbers, the main effect size was robust. We recommend implementation alongside evaluation in wider clinical settings and patient populations.
Assuntos
Cuidados Paliativos na Terminalidade da Vida/economia , Recidiva Local de Neoplasia/psicologia , Recidiva Local de Neoplasia/reabilitação , Qualidade de Vida , Análise Custo-Benefício/economia , Análise Custo-Benefício/estatística & dados numéricos , Feminino , Custos de Cuidados de Saúde/estatística & dados numéricos , Cuidados Paliativos na Terminalidade da Vida/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/economia , Recidiva Local de Neoplasia/epidemiologia , Reabilitação/economia , Reabilitação/estatística & dados numéricos , Sobreviventes/estatística & dados numéricos , Resultado do Tratamento , Reino Unido/epidemiologiaRESUMO
OBJECTIVE: To discuss the present status and progress of clinical research on recurrence of gastric cancer after surgery, including patterns, clinicopathologic factors, prognosis, detection, diagnosis, prevention, and treatment strategies. DATA SOURCES: The data used in this review were mainly from PubMed articles published in English from 2000 to August 2011. The search terms were "gastric cancer" and "recurrence". STUDY SELECTION: Articles were selected if they involved clinicopathologic factors, detection methods, and treatment strategies of recurrence of gastric cancer. RESULTS: Peritoneal recurrence is the most common pattern in recurrence of gastric cancer. The main risk factors for recurrence of gastric cancer are tumor stage, including depth of tumor invasion and lymph node metastasis, and Borrmann classification. The prognosis of patients with recurrence is very poor, especially patients with peritoneal recurrence. Systemic chemotherapy is still the main treatment method for patients with recurrent cancer. If complete resection can be accomplished, some benefits may be obtained from surgery for recurrence. However, standard treatment for patients with recurrence has not yet been established. CONCLUSIONS: Early detection and diagnosis of recurrence is quite crucial for treatment and prognosis. The optimal therapeutic strategy for recurrence should be based on a multidisciplinary assessment and the patient's individual state and should involve combined therapy.
Assuntos
Recidiva Local de Neoplasia/reabilitação , Neoplasias Gástricas/cirurgia , Biomarcadores Tumorais/análise , Humanos , Recidiva Local de Neoplasia/diagnóstico , Recidiva Local de Neoplasia/cirurgia , Recidiva Local de Neoplasia/terapia , Estadiamento de Neoplasias , Prognóstico , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/mortalidade , Neoplasias Gástricas/patologiaAssuntos
Dermatofibrossarcoma/cirurgia , Neoplasias Faciais/cirurgia , Procedimentos de Cirurgia Plástica/métodos , Neoplasias Cutâneas/cirurgia , Dermatofibrossarcoma/reabilitação , Neoplasias Faciais/reabilitação , Feminino , Seguimentos , Sobrevivência de Enxerto , Humanos , Microcirurgia/métodos , Pessoa de Meia-Idade , Músculo Esquelético/transplante , Invasividade Neoplásica , Recidiva Local de Neoplasia/reabilitação , Recidiva Local de Neoplasia/cirurgia , Neoplasias Nasais/reabilitação , Neoplasias Nasais/cirurgia , Exenteração Orbitária/reabilitação , Próteses e Implantes , Radioterapia Adjuvante , Reto do Abdome/transplante , Neoplasias Cutâneas/reabilitação , Transplante de Pele/métodos , Retalhos Cirúrgicos , Infecção da Ferida Cirúrgica/etiologiaRESUMO
The amount and quality of available data on secondary and tertiary prevention of urological tumors are to a large extent unsatisfactory. In the areas of nutrition and supplementary diet the consumption of tomatoes and especially tomato products could have a beneficial effect on the course of the disease for patients with prostate cancer, whereas there is evidence that the consumption of foodstuffs containing calcium (milk and milk products) and linolenic acid as well as a fat-rich diet accelerate tumor progression. Despite as yet unsatisfactory data, men with urothelial tumors or prostate cancer should abstain from smoking and undertake sports activities. For medicinal measures the administration of 5-alpha-reductase inhibitors and bone-promoting substances for patients with prostate cancer are under discussion. The effectiveness of the substances zoledronate and denosumab has been demonstrated in prospective randomized studies. The authors recommend that the scientifically neglected field of tertiary prevention of urological tumors should in future be included as a core factor of scientific investigations.
Assuntos
Recidiva Local de Neoplasia/prevenção & controle , Prevenção Secundária , Prevenção Terciária , Neoplasias Urológicas/prevenção & controle , Inibidores de 5-alfa Redutase/uso terapêutico , Antineoplásicos Hormonais/administração & dosagem , Conservadores da Densidade Óssea/uso terapêutico , Carcinoma de Células de Transição/etiologia , Carcinoma de Células de Transição/prevenção & controle , Carcinoma de Células de Transição/reabilitação , Terapia Combinada , Progressão da Doença , Comportamento Alimentar , Humanos , Solanum lycopersicum , Masculino , Recidiva Local de Neoplasia/etiologia , Recidiva Local de Neoplasia/reabilitação , Fitoterapia , Estudos Prospectivos , Neoplasias da Próstata/etiologia , Neoplasias da Próstata/prevenção & controle , Neoplasias da Próstata/reabilitação , Ensaios Clínicos Controlados Aleatórios como Assunto , Fatores de Risco , Neoplasias da Bexiga Urinária/etiologia , Neoplasias da Bexiga Urinária/prevenção & controle , Neoplasias da Bexiga Urinária/reabilitação , Neoplasias Urológicas/etiologia , Neoplasias Urológicas/reabilitaçãoRESUMO
The article approaches with the question how preservation of function after treatment of head and neck cancer (HNC) can be defined and measured across treatment approaches. On the basis of the "International Classification of Functioning, Disability and Health (ICF)" a series of efforts are summarized how all relevant aspects of the interdisciplinary team can be integrated into a common concept.Different efforts on the development, validation and implementation of ICF Core Sets for head and neck cancer (ICF-HNC) are discussed. The ICF-HNC covers organ-based problems with food ingestion, breathing, and speech, as well as psychosocial difficulties.Relationships between the ICF-HNC and well-established outcome measures are illustrated. This enables the user to integrate different aspects of functional outcome into a consolidated approach towards preservation/rehabilitation of functioning after HNC - applicable for a variety of treatment-approaches and health-professions.
Assuntos
Avaliação da Deficiência , Neoplasias Otorrinolaringológicas/classificação , Atividades Cotidianas/classificação , Assistência ao Convalescente/classificação , Protocolos Antineoplásicos/classificação , Terapia Combinada/efeitos adversos , Terapia Combinada/classificação , Comportamento Cooperativo , Técnica Delphi , Definição da Elegibilidade , Necessidades e Demandas de Serviços de Saúde , Humanos , Comunicação Interdisciplinar , Classificação Internacional de Doenças , Recidiva Local de Neoplasia/classificação , Recidiva Local de Neoplasia/reabilitação , Neoplasias Otorrinolaringológicas/reabilitação , Pesquisa , Inquéritos e QuestionáriosRESUMO
BACKGROUND: Tumours of nasal skin or mucosa are common, and can usually be treated with limited surgical excision or radiotherapy. This paper highlights a subset of high risk tumours which require rhinectomy for complete oncological clearance. METHOD: Retrospective case note review of 14 patients undergoing rhinectomy for nasal tumours. Clinical and histological findings, treatment and outcome are reviewed and discussed. RESULTS: Forty-three per cent of patients had recurrent disease and underwent rhinectomy as a salvage procedure following previous surgery or radiotherapy. Most tumours (79 per cent) were basal cell carcinoma or squamous cell carcinoma. After a mean follow up of 30.1 months (range, zero to 96 months), seven patients (50 per cent) were alive and disease-free. Reconstruction was most commonly with a prosthesis. CONCLUSION: Rhinectomy is an oncologically sound procedure for the management of high risk nasal malignancies. Prosthetic rehabilitation can be an excellent alternative to surgery, particularly in those patients unsuitable for major reconstruction.
Assuntos
Procedimentos Cirúrgicos Nasais/métodos , Neoplasias Nasais/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Basocelular/patologia , Carcinoma Basocelular/reabilitação , Carcinoma Basocelular/cirurgia , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/reabilitação , Carcinoma de Células Escamosas/cirurgia , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Nasais/estatística & dados numéricos , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/reabilitação , Recidiva Local de Neoplasia/cirurgia , Neoplasias Nasais/patologia , Neoplasias Nasais/reabilitação , Próteses e Implantes , Implantação de Prótese/métodos , Procedimentos de Cirurgia Plástica/métodos , Procedimentos de Cirurgia Plástica/reabilitação , Reoperação , Estudos Retrospectivos , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/reabilitação , Neoplasias Cutâneas/cirurgia , Retalhos Cirúrgicos , Resultado do TratamentoAssuntos
Necessidades e Demandas de Serviços de Saúde/organização & administração , Nível de Saúde , Neoplasias/psicologia , Neoplasias/reabilitação , Educação de Pacientes como Assunto , Sobreviventes/psicologia , Adolescente , Criança , Pré-Escolar , Estudos Transversais , Alemanha , Humanos , Lactente , Estudos Longitudinais , Recidiva Local de Neoplasia/epidemiologia , Recidiva Local de Neoplasia/psicologia , Recidiva Local de Neoplasia/reabilitação , Neoplasias/epidemiologia , Segunda Neoplasia Primária/epidemiologia , Segunda Neoplasia Primária/psicologia , Segunda Neoplasia Primária/reabilitação , Equipe de Assistência ao Paciente/organização & administração , Sistema de Registros/estatística & dados numéricos , Inquéritos e Questionários , Adulto JovemRESUMO
Relating to the report of Irwin and colleagues in this issue of the journal (beginning on page 522), this perspective discusses exercise training interventions as secondary prevention in breast cancer survivors. Burgeoning observational evidence indicates that prescribing aerobic exercise of 3 hours or more per week could have meaningful mortality and morbidity benefits for breast cancer survivors. Adherence to this exercise prescription, however, will require an infrastructure to guide survivors and to address the common clinical treatment sequelae that might interfere with survivors' ability to regularly perform this level of activity (e.g., symptoms related to estrogen deprivation, arthralgias due to aromatase inhibitors, fatigue, lymphedema, chemotherapy-induced peripheral neuropathy, osteoporosis, upper-extremity functional impairments, and overall functional decline). On the basis of cardiac rehabilitation, a model is proposed to integrate exercise prescription into breast cancer survivor clinical care, with referral to community-based programs for most women.
Assuntos
Neoplasias da Mama/prevenção & controle , Terapia por Exercício/métodos , Exercício Físico , Recidiva Local de Neoplasia/prevenção & controle , Prevenção Secundária/métodos , Neoplasias da Mama/reabilitação , Feminino , Humanos , Recidiva Local de Neoplasia/reabilitaçãoRESUMO
Chondrosarcoma is a malignant tumor in which the tumor cells produce cartilage but not bone. The recommended management is wide local or radical excision, followed by surgical and prosthetic reconstruction. This article explains postsurgical prosthetic rehabilitation of a chondrosarcoma patient by means of intraoral acrylic, and extraoral silicone prosthesis for restoration of normal orofacial function and appearance.
Assuntos
Condrossarcoma/cirurgia , Neoplasias Maxilares/cirurgia , Prótese Maxilofacial , Desenho de Prótese , Condrossarcoma/reabilitação , Planejamento de Prótese Dentária , Planejamento de Dentadura , Prótese Total Superior , Face , Seguimentos , Humanos , Masculino , Maxila/cirurgia , Neoplasias Maxilares/reabilitação , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/reabilitação , Recidiva Local de Neoplasia/cirurgia , Nariz , Obturadores Palatinos , Próteses e Implantes , Procedimentos de Cirurgia Plástica/métodosRESUMO
Cervical cancer is a public health problem in Brazil, with annual incidence rates of 20-40 cases/100,000 women. Most patients with recurrent disease have symptoms from locoregional disease and may develop renal failure. This study aims to evaluate the outcome of patients with recurrent cervical cancer who underwent percutaneous nephrostomy (PN). We reviewed the medical records of 50 such patients who were referred to the Palliative Care Unit of the Brazilian National Cancer Institute from January 2002 to October 2006. Median age was 44 years (range, 26-67 years). Half the patients had improvement in pain or uremic symptoms, and seven (14%) had improved performance status (PS) after the procedure. Thirty patients (60%) had improvement of renal function; median creatinine levels before and after PN were 6.4 and 3.7mg/dL, respectively (P<0.05). Median overall survival after PN was 8.9 weeks (95% confidence interval [CI]: 7.4-10.3). Median survival was 9.9 weeks (95% CI: 8.7-11.0) in 40 patients with baseline PS 1-3 and one week (95% CI: 0.1-1.9) in 10 patients with PS 4 (log rank, P<0.0001). Median survival in patients with and without improvement of renal function after PN was 10.0 weeks (95% CI: 8.6-11.3) and 2.6 weeks (95% CI: 0-11.3), respectively (log rank, P=0.01). Twenty-nine patients (58%) died from renal failure. Complications were mainly urinary tract infection (n=10), catheter loss (n=9), and bleeding (n=1). These data suggest that PN can be of clinical benefit for carefully selected patients with recurrent cervical cancer.
Assuntos
Nefropatias/reabilitação , Recidiva Local de Neoplasia/reabilitação , Nefrostomia Percutânea/métodos , Cuidados Paliativos/métodos , Dor Pélvica/prevenção & controle , Neoplasias do Colo do Útero/reabilitação , Adulto , Idoso , Feminino , Humanos , Nefropatias/etiologia , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/complicações , Estudos Retrospectivos , Resultado do Tratamento , Neoplasias do Colo do Útero/complicaçõesRESUMO
Presented here is a 16-year-old girl who was referred on 30th January 1996 with diagnosis of cord compression with spastic paraplegia with sensory level at T7/T8. CT scan myelogam confirmed soft tissue density mass displacing cord to the left with no dye being seen beyond T3. Thoracic spine decompressive laminectomy was performed on 1st January 1996 at Nairobi West Hospital extending from T3 to T6 level, which revealed a fibrous haemorrhagic tumour. Histology showed meningioma (mixed fibrous type and meningoepitheliomatous type) with many psammoma bodies. She had a stormy post-operative period, with infection and wound dehiscence. This was treated with appropriate antibiotics and wound care. She was eventually rehabilitated and was able to walk with the aid of a walking frame because of persistent spasticity of right leg. She was seen once as an outpatient by author on 6th July 1996, she was able to use the walking frame, but the right leg was still held in flexion deformity at the knee. She was thus referred to an orthopaedic surgeon for possible tenotomy. She was able to resume her studies at the University ambulating using a wheel chair and walking frame. She presented with worsening of symptoms in 2001 (five years after her first surgery). MRI scan thoracic spine revealed a left anterolateral intradural lesion extending from T3 to T5 vertebral body level compressing and displacing the spinal cord. She had a repeat surgery on 6th March 2001 at Kenyatta National Hospital; spastic paraparesis and urinary incontinenece persisted. She also developed bed sores and recurrent urinary tract infections. She was followed up by the author and other medical personnel in Mwea Mission Hospital where she eventually succumbed in 2005, nine years after her first surgery. This case is presented as a case of incompletely excised spinal meningioma to highlight some of the problems of managing spinal meningiomas when operating microscope and embolisation of tumours are not readily available. Also the family experienced financial constraint in bringing the patient for regular follow-up, and getting access to appropriate antibiotics, catheters and urine bags.
Assuntos
Neoplasias Meníngeas/cirurgia , Meningioma/cirurgia , Recidiva Local de Neoplasia/cirurgia , Complicações Pós-Operatórias , Neoplasias da Medula Espinal/cirurgia , Adolescente , Descompressão Cirúrgica , Evolução Fatal , Feminino , Humanos , Laminectomia , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/reabilitação , Meningioma/patologia , Meningioma/reabilitação , Espasticidade Muscular/etiologia , Espasticidade Muscular/reabilitação , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/reabilitação , Paraplegia/etiologia , Paraplegia/reabilitação , Complicações Pós-Operatórias/reabilitação , Reoperação , Compressão da Medula Espinal/diagnóstico , Compressão da Medula Espinal/cirurgia , Neoplasias da Medula Espinal/patologia , Neoplasias da Medula Espinal/reabilitação , Incontinência Urinária/etiologiaRESUMO
OBJECTIVES: We evaluated patients who underwent surgical treatment for giant cell tumor of the wrist with regard to recurrence rates, factors influencing tumor recurrence, complications, and postoperative functional and emotional status of the patients. METHODS: The study included 23 patients (6 males, 17 females; mean age 31.6 years; range 12 to 74 years) who were treated surgically for giant cell tumor of the wrist. Grading, assessment of surgical margins, and functional evaluation were performed according to the Enneking's criteria. The effects of tumor volume, soft tissue extension, and selected surgical therapy on recurrence were investigated. Joint movements and stability, postoperative pain, presence of deformity, muscle strength, limitations in functional activities, and patient satisfaction were evaluated. The mean follow-up period was 6.7 years. RESULTS: Of all the patients, 69% had stage 2 and 23% had stage 3 tumors. There was no significant correlation between tumor volume and recurrence (p=0.22). Recurrences were observed in three (33%) of nine patients with soft tissue extension and in four (28.6%) of 14 patients without soft tissue extension. Recurrence rates were 33.3% in those who were treated by curettage alone (n=3), 50% with curettage and grafting (n=6), 50% with curettage and bone cement (n=2), and 16% in those who underwent wide excision (n=12). CONCLUSION: The most important factor influencing recurrence rate in giant cell tumors is the extent of surgical resection. At least marginal resection must be considered in patients with stage 2 and 3 lesions especially in cases with soft tissue extension. Adjunctive therapy should be added if curettage is considered.
Assuntos
Neoplasias Ósseas/cirurgia , Tumor de Células Gigantes do Osso/cirurgia , Recidiva Local de Neoplasia/cirurgia , Punho/patologia , Adolescente , Adulto , Idoso , Neoplasias Ósseas/diagnóstico por imagem , Neoplasias Ósseas/patologia , Neoplasias Ósseas/reabilitação , Criança , Feminino , Tumor de Células Gigantes do Osso/diagnóstico por imagem , Tumor de Células Gigantes do Osso/patologia , Tumor de Células Gigantes do Osso/reabilitação , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/diagnóstico por imagem , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/reabilitação , Estadiamento de Neoplasias , Procedimentos Ortopédicos/métodos , Radiografia , Procedimentos de Cirurgia Plástica/métodos , Recuperação de Função Fisiológica , Resultado do TratamentoRESUMO
GOALS OF WORK: The effects of psychosocial group interventions on improving quality of life (QOL) for patients with recurrent breast cancer are not well known. The objective of this study was to assess the feasibility of a psychosocial group intervention in Japanese women with first recurrence of breast cancer. PATIENTS AND METHOD: The subjects were consecutively selected from among patients who were diagnosed with a first recurrence of breast cancer. We conducted a 6-week psychosocial group intervention. QOL was assessed using the Profile of Mood States (POMS), the Impact of Event Scale-Revised, the Mental Adjustment to Cancer (MAC) scale, and the European Organization for Research and the Treatment of Cancer (EORTC) Quality of Life Questionnaire-Cancer 30/Breast module 23 (QLQ-C30/Br23) at baseline then immediately and 3 and 6 months after completion of the intervention. RESULTS: Among 58 eligible patients, written consent was obtained from 28 (48%), and the final evaluation was conducted on 19 subjects. The repeated measured analysis of variance (ANOVA) revealed a significant change in tension-anxiety, depression-dejection, anger-hostility and total mood disturbance on the POMS, helplessness/hopelessness on the MAC scale, and body image and future perspective on the QLQ-C30/Br23. Dunnett's test revealed a significant difference in these scores between baseline and 3 months after the intervention but no difference between baseline and 6 months after the intervention. CONCLUSION: These results suggested the possibility of a short-term effectiveness of the intervention; however the results were inconclusive because of selected small samples.